These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21359560)

  • 1. Rapid discovery of inhibitors of Toxoplasma gondii using hybrid structure-based computational approach.
    Kortagere S; Mui E; McLeod R; Welsh WJ
    J Comput Aided Mol Des; 2011 May; 25(5):403-11. PubMed ID: 21359560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Plasmodium Atg3-Atg8 Interaction Inhibitors Identifies Novel Alternative Mechanisms of Action in Toxoplasma gondii.
    Varberg JM; LaFavers KA; Arrizabalaga G; Sullivan WJ
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A focused small-molecule screen identifies 14 compounds with distinct effects on Toxoplasma gondii.
    Kamau ET; Srinivasan AR; Brown MJ; Fair MG; Caraher EJ; Boyle JP
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5581-90. PubMed ID: 22908155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxylamine and Carboxymethoxylamine Can Inhibit
    Li J; Guo H; Galon EM; Gao Y; Lee SH; Liu M; Li Y; Ji S; Jia H; Xuan X
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907178
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo.
    Mui EJ; Schiehser GA; Milhous WK; Hsu H; Roberts CW; Kirisits M; Muench S; Rice D; Dubey JP; Fowble JW; Rathod PK; Queener SF; Liu SR; Jacobus DP; McLeod R
    PLoS Negl Trop Dis; 2008 Mar; 2(3):e190. PubMed ID: 18320016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
    McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
    ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of T. gondii myosin light chain-1 as a direct target of TachypleginA-2, a small-molecule inhibitor of parasite motility and invasion.
    Leung JM; Tran F; Pathak RB; Poupart S; Heaslip AT; Ballif BA; Westwood NJ; Ward GE
    PLoS One; 2014; 9(6):e98056. PubMed ID: 24892871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering ophthalmic adaptive inhibitors targeting RON4 of Toxoplasma gondii: An integrative in silico approach.
    Vetrivel U; Nagarajan H
    Life Sci; 2018 Nov; 213():82-93. PubMed ID: 30326220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for small molecule inhibitors of Toxoplasma gondii.
    Kortagere S
    Expert Opin Drug Discov; 2012 Dec; 7(12):1193-206. PubMed ID: 22998671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
    Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F
    Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small-molecule cell-based screen led to the identification of biphenylimidazoazines with highly potent and broad-spectrum anti-apicomplexan activity.
    Moine E; Denevault-Sabourin C; Debierre-Grockiego F; Silpa L; Gorgette O; Barale JC; Jacquiet P; Brossier F; Gueiffier A; Dimier-Poisson I; Enguehard-Gueiffier C
    Eur J Med Chem; 2015 Jan; 89():386-400. PubMed ID: 25462254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo.
    Mui EJ; Jacobus D; Milhous WK; Schiehser G; Hsu H; Roberts CW; Kirisits MJ; McLeod R
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3463-7. PubMed ID: 16048961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triazole-based compound as a candidate to develop novel medicines to treat toxoplasmosis.
    Dzitko K; Paneth A; Plech T; Pawełczyk J; Węglińska L; Paneth P
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7583-5. PubMed ID: 25288090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auranofin is highly efficacious against Toxoplasma gondii in vitro and in an in vivo experimental model of acute toxoplasmosis.
    Andrade RM; Chaparro JD; Capparelli E; Reed SL
    PLoS Negl Trop Dis; 2014; 8(7):e2973. PubMed ID: 25079790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A protein extract and a cysteine protease inhibitor enriched fraction from Jatropha curcas seed cake have in vitro anti-Toxoplasma gondii activity.
    Soares AM; Carvalho LP; Melo EJ; Costa HP; Vasconcelos IM; Oliveira JT
    Exp Parasitol; 2015 Jun; 153():111-7. PubMed ID: 25816973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sterculic Acid and Its Analogues Are Potent Inhibitors of Toxoplasma gondii.
    Hao P; Alaraj IQ; Dulayymi JR; Baird MS; Liu J; Liu Q
    Korean J Parasitol; 2016 Apr; 54(2):139-45. PubMed ID: 27180571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antagonistic and indifferent activity of combination of 3-deoxyanthocyanidins against Toxoplasma gondii.
    Abugri DA; Witola WH; Jaynes JM
    Parasitol Res; 2017 Dec; 116(12):3387-3400. PubMed ID: 29086004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Toxoplasma gondii and Plasmodium falciparum infections in vitro by NSC3852, a redox active antiproliferative and tumor cell differentiation agent.
    Strobl JS; Seibert CW; Li Y; Nagarkatti R; Mitchell SM; Rosypal AC; Rathore D; Lindsay DS
    J Parasitol; 2009 Feb; 95(1):215-23. PubMed ID: 18837587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the bumped kinase inhibitor BKI-1708 against the cyst-forming apicomplexan parasites Toxoplasma gondii and Neospora caninum in vitro and in experimentally infected mice.
    de Sousa MCF; Imhof D; Hänggeli KPA; Choi R; Hulverson MA; Arnold SLM; Van Voorhis WC; Fan E; Roberto SS; Ortega-Mora LM; Hemphill A
    Int J Parasitol Drugs Drug Resist; 2024 Aug; 25():100553. PubMed ID: 38917582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites.
    Murata Y; Sugi T; Weiss LM; Kato K
    PLoS One; 2017; 12(6):e0178203. PubMed ID: 28609444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.